Health Technology Assessment World Europe 2012
December 4 - 6, 2012
london , United Kingdom
The most influential meeting on HTA for pharmaceutical products
At Health Technology Assessment World Europe thought leaders in HTA from leading biopharmaceutical companies, government agencies, academic institutions, contract service organisations and consultancies, will convene to discuss pioneering HTA strategy.
We have representatives from all the major HTA agencies as well as experts from the key pharma companies like Bayer Pharma, Novo Nordisk and Novartis.
• Keynote Speakers
Lizzie Amis,Pippa Anderson,Elise Berliner Ph.D.,Meindert Boysen,Dr. Anna Bucsics,Paul Catchpole PhD and many more.
Come to Health Technology Assessment World and learn:
• HTA policy and practice in Europe, USA and rest of the World
• HTA in reimbursement decisions
•Cooperation between regulatory bodies and HTA agencies
• How to demonstrate comparative effectiveness and outcomes research
• Case studies of HTA policy, practice and assessment methods
• HTA for speciality and high priced drugs
• Value based pricing, risk sharing schemes and reimbursement
• Role of patients in HTA
Who should attend:
This event will be attended by pharmaceutical and biotech professionals working in the following departments:
• HTA
• Market Access
• Health Economics
• Outcomes Research
• Health Policy
• Epidemiology
• Reimbursement
• Pricing
• Pharmacoeconomics
At Health Technology Assessment World Europe thought leaders in HTA from leading biopharmaceutical companies, government agencies, academic institutions, contract service organisations and consultancies, will convene to discuss pioneering HTA strategy.
We have representatives from all the major HTA agencies as well as experts from the key pharma companies like Bayer Pharma, Novo Nordisk and Novartis.
• Keynote Speakers
Lizzie Amis,Pippa Anderson,Elise Berliner Ph.D.,Meindert Boysen,Dr. Anna Bucsics,Paul Catchpole PhD and many more.
Come to Health Technology Assessment World and learn:
• HTA policy and practice in Europe, USA and rest of the World
• HTA in reimbursement decisions
•Cooperation between regulatory bodies and HTA agencies
• How to demonstrate comparative effectiveness and outcomes research
• Case studies of HTA policy, practice and assessment methods
• HTA for speciality and high priced drugs
• Value based pricing, risk sharing schemes and reimbursement
• Role of patients in HTA
Who should attend:
This event will be attended by pharmaceutical and biotech professionals working in the following departments:
• HTA
• Market Access
• Health Economics
• Outcomes Research
• Health Policy
• Epidemiology
• Reimbursement
• Pricing
• Pharmacoeconomics
Venue
Location: Millennium Gloucester Hotel & Conference Centre
This modern, four-star deluxe hotel is located in the heart of Kensington - less than a minutes walk from Gloucester Road underground station. The hotel offers an understated elegance with a relaxed..
Contact
4 -18 Harrington Gardens London SW7 4LH UK Twickenham , United Kingdom
+442073736030
+442073736030
Related events
Health Technology Assessment World Europe December 4 - 5, 2013
Health Technology Assessment World Europe December 4 - 6, 2012
Health Technology Assessment World Europe November 29 - December 2, 2011
Health Technology Assessment World Europe December 7 - 10, 2010
